BPA for palforzia
Ended Awarded Last action
- Contract number
- 36E79721A0004
- Awardee
-
Aimmune Therapeutics, Inc. UEI E3ULPC7MFBK9
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $14,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Blanket Purchase Agreement was awarded as a single award by the Department of Veterans Affairs National Acquisition Center to Aimmune Therapeutics, Inc. The potential value of the BPA is $14 million. The BPA is for the procurement of Palforzia, which is intended to reduce the frequency and severity of allergic reactions to peanuts in patients aged 4 through 17 years. No set-aside was used in the awarding of this BPA. The period of performance for orders placed against the BPA extends through April 14, 2021.
The BPA functions as an indefinite delivery vehicle to facilitate orders for Palforzia through task orders or price lists. As the awarding agency, the VA National Acquisition Center likely established this BPA to streamline the procurement of Palforzia to efficiently treat peanut allergies among qualified VA patients during the period of performance. By consolidating purchases of this medication through a single award BPA rather than numerous individual contracts, the VA aims to reduce administrative costs and better manage funding for this important clinical program.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0004?
36E79721A0004 was awarded to Aimmune Therapeutics, Inc. by National Acquisition Center (Headquarters) on October 17, 2020.
How much is contract 36E79721A0004 worth?
36E79721A0004's own ceiling is $14,000,000.
Who can order from contract 36E79721A0004?
36E79721A0004 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0004 under another contract?
Yes. 36E79721A0004 is a blanket purchase agreement under 36F79721D003E, a federal supply schedule.
Was contract 36E79721A0004 competed?
The extent of competition for 36E79721A0004 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV